ODE Systems Approach, Revised Guidance To Enhance Premarket Programs
This article was originally published in The Gray Sheet
Executive Summary
FDA has revised its guidance on early determination and agreement meetings to reassure sponsors that each meeting is not a "one-shot" opportunity.
You may also be interested in...
Given Imaging Guides Ingestible Microcapsule Through De Novo Process
Given Imaging hopes to be the second company to have a product cleared by way of FDA's de novo program this year by proposing to include several cautionary statements in the labeling of its wireless endoscopy diagnostic imaging system.
Given Imaging Guides Ingestible Microcapsule Through De Novo Process
Given Imaging hopes to be the second company to have a product cleared by way of FDA's de novo program this year by proposing to include several cautionary statements in the labeling of its wireless endoscopy diagnostic imaging system.
FDA Early Collaboration Guidance Offers Incentives For Formal Meetings
Device manufacturers have the option of postponing agreement meetings until informal "pre-meetings" with FDA are completed, according to a revised guidance outlining early collaborations under the FDA Modernization Act of 1997.